Real Issues in Treating Lung Cancer Patients
CME Monograph - October 2006
This CME monograph was developed for oncologists and other medical professionals who treat lung cancer patients by multidisciplinary leaders in lung cancer treatment and patient care, including Thomas J. Lynch, Jr., MD Chief Oncology/ Hematology, Massachusetts General Hospital, Alan B. Sandler, MD, Medical Director, Thoracic Oncology Vanderbilt-Ingram Cancer Center, Paul J. Hesketh, MD, Chief, Division of Hematology Oncology Caritas St. Elizabeth's Medical Center, William F. Pirl, MD, Psychiatric Oncology Service, Massachusetts General Hospital, Kevin A. Raskin, MD, Department of Orthopedic Oncology, Massachusetts General Hospital, M. Dror Michaelson, MD, PhD, Dept of Hematology/Oncology, Massachusetts General Hospital, and Jennifer S. Temel, MD, Dept of Oncology, Massachusetts General Hospital. It was supported by educational grants from industry. The educational objectives of this enduring CME activity are to: enhance participants ability to utilize systemic therapy in treating lung cancer patients; manage emesis and anemia as side effects of systemic therapy in lung cancer patients; assess and treat bone complications in lung cancer patients; assess depression and anxiety in lung cancer patients; and counselpatients and families on palliative and hospice care for advanced disease.
